20/20 Biolabs, Inc. (AIDX) Live Share Price, Invest From India

20/20 Biolabs, Inc. Stock Performance

as on October 17, 2026 at 2:16 pm IST

Day's Low
Day's High
$0.26
Day's Price Range
$0.28
$0.26
0.23%
Downside
7.44%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$0.26
100.00%
Downside
-100.00%
Upside

20/20 Biolabs, Inc. share price movements today

Previous Close: $0.28
Open: $0.28
Volume: 1.3M
Market Cap: $3.5M
Day's Low - High: $0.26 - $0.28

20/20 Biolabs, Inc. Historical Returns

1 Month Return: -44.73 %
3 Month Return: -49.65 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

20/20 Biolabs, Inc. Stock Fundamentals & Key Indicators

Check 20/20 Biolabs, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.5M

EPS (TTM)

-0.76

Dividend Yield

0.00%

PE Ratio (TTM)

-0.36

Industry PE ratio

-2.38

PEG Ratio

0.00

Return On Equity TTM

-387.27%

20/20 Biolabs, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of 20/20 Biolabs, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
20/20 Biolabs, Inc.	NA	$3.5M	NA	-0.36	31.52%	0.00%
Medtronic	Buy	$120.5B	-25.83%	23.34	66.69%	3.00%
Edwards Lifesciences	Buy	$50.8B	-22.79%	50.63	77.98%	0.00%
Abbott Laboratories	StrongBuy	$178.2B	-10.72%	33.66	56.80%	2.41%
Stryker	StrongBuy	$108.4B	10.10%	30.14	65.17%	1.25%

See all

Indian Investors' Interest in 20/20 Biolabs, Inc. Stock

Search interest for 20/20 Biolabs, Inc. Stock has increased by 29% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 18, 2026 to October 18, 2026

Change:29% versus previous 30 day period

20/20 Biolabs, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Dec 2024	Sep 2025	Mar 2026	Jun 2026
Total Revenue	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0
Operating Income	-1	-1	-1	0	-1	-1
EBITDA	-1	-1	-1	0	-1	-1
Interest Expense	0	0	-	0	0	0
Depreciation	0	0	0	0	0	0
Income Before Tax	-1	-1	-1	0	-2	-1
Income Tax Expense	-	-	-	-	-	-
Net Income	-1	-1	-1	0	-2	-1
Net Profit Margin	0.44%	11.64%	30.41%	34.71%	17.80%	41.71%

20/20 Biolabs, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Mar 2026
Total Revenue	0	0	0	2	9	11	1	1	2
Gross Profit	0	0	0	0	4	5	0	0	0
Operating Income	-1	-1	-2	-2	1	1	-6	-5	-3
EBITDA	-1	-1	-2	-1	2	1	-6	-5	-3
Interest Expense	-	-	-	-	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-1	-2	-2	2	2	-6	-5	-3
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-1	-1	-2	-2	2	2	-6	-5	-3
Net Profit Margin	41.80%	21.46%	8.46%	37.64%	48.79%	46.31%	7.66%	20.56%	29.56%

20/20 Biolabs, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2023	Jun 2023	Dec 2024	Sep 2025	Mar 2026	Jun 2026
Net Income	-1	-1	-1	0	-2	-1
Operating Cash Flow	-1	-1	0	0	-1	0
Investing Cash Flow	0	0	-	-	0	0
Financing Cash Flow	0	0	0	0	4	0
Change in Cash	7	-1	0	0	3	0

20/20 Biolabs, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Mar 2026
Net Income	-1	-1	-2	-2	2	2	-6	-5	-3,738
Operating Cash Flow	-1	-1	-2	-2	-1	5	-4	-2	-1,919
Investing Cash Flow	0	0	-1	1	0	0	0	-	-
Financing Cash Flow	1	3	1	3	1	0	0	0	1,161
Change in Cash	0	2	-2	2	0	5	-4	-2	-758

Global Institutional Holdings in 20/20 Biolabs, Inc.

Check out the Institutions with significant holdings in 20/20 Biolabs, Inc..

Funds	Holdings
Vanguard	0.19%

Insights on 20/20 Biolabs, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, AIDX stock has moved down by -30.5%

About 20/20 Biolabs, Inc.

20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.

Organisation	20/20 Biolabs, Inc.
Headquarters	15810 Gaither Road, Gaithersburg, MD, 20877, US
Industry	Medical - Care Facilities
CEO	Jonathan Cohen

Key Management of 20/20 Biolabs, Inc.

Name	Title
Mr. Jonathan Cohen	Founder, CEO, President & Director
Dr. Jiming Zhou Ph.D.	Chief Operating Officer
Dr. Michael Saul Lebowitz Ph.D.	Chief Scientific Officer
Mr. Alan B. Bergman	Chief Financial Officer
Mr. David Lees	Director of Sales
Mr. Ronald R. Baker	Chief Business Officer
Marc Gordon	Controller

FAQs

What is 20/20 Biolabs, Inc. share price today?

20/20 Biolabs, Inc. share price today is $0.26 as on October 17, 2026 at 8:46 am IST at the close of the market. 20/20 Biolabs, Inc. share today touched a day high of $0.28 and a low of $0.26.

What is the 52 week high and 52 week low for 20/20 Biolabs, Inc. share?

20/20 Biolabs, Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. 20/20 Biolabs, Inc. stock price today i.e. October 17, 2026 at 8:46 am IST is closed at $0.26,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is 20/20 Biolabs, Inc.'s market capitalisation today?

20/20 Biolabs, Inc. market capitalisation is $0.00T as on October 17, 2026 at 8:46 am IST.

How to invest in 20/20 Biolabs, Inc. Stock (AIDX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for 20/20 Biolabs, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy 20/20 Biolabs, Inc. Stock (AIDX) from India?

Indian investors can start investing in 20/20 Biolabs, Inc. (AIDX) shares with as little as ₹94.95999908447266 or $1 (as of October 18, 2026 at 4:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in 20/20 Biolabs, Inc. stock (as per the Rupee-Dollar exchange rate as on October 18, 2026 at 4:42 am IST). Based on 20/20 Biolabs, Inc. share’s latest price of $0.26 as on October 17, 2026 at 8:46 am IST, you will get 38.3730 shares of 20/20 Biolabs, Inc.. Learn more about fractional shares .